AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30909787
Drug: Local intra‐arterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local intra‐arterial prostaglandin therapy
Trial: 31160549
Drug: Prolonged-release tacrolimus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged-release tacrolimus (Arm 1: 0.2 mg/kg/day, Arm 2: 0.15-0.175 mg/kg/day, Arm 3: 0.2 mg/kg/day delayed until Day 5)
Trial: 31160549
Drug: Prolonged-release tacrolimus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged-release tacrolimus (early lower-dose and delayed higher-dose regimens)
Trial: 31160549
Drug: Prolonged-release tacrolimus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged-release tacrolimus (early-lower tacrolimus arm with older donors, delayed higher-dose tacrolimus arm with younger donors)
Trial: 25961367
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment according to the diagnostic algorithm
Trial: 21392712
Drug: High-calcium (HC)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-calcium (HC) diet supplying 1,500 mg calcium/d
Trial: 10668706
Drug: Lu25-109 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lu25-109 25 mg tid
Trial: 10668706
Drug: Lu25-109 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lu25-109 50 mg tid
Trial: 10668706
Drug: Lu25-109 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lu25-109 100 mg tid
Trial: 9058328
Drug: No agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No agent (VC)
Trial: 23169319
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg SC abatacept weekly
Trial: 23169319
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg SC adalimumab biweekly
Trial: 21494062
Drug: 16-session disorder-specific
RxNorm normalized name: PACIFIC OYSTER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16-session disorder-specific SAD treatment program including parent training and classical cognitive-behavioral therapy (CBT) components
Trial: 17882417
Drug: Dalteparin (5,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin (5,000 U sub-Q daily)
Trial: 9363277
Drug: Single breath
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single breath vital capacity rapid inhalation induction (VCRII)
Trial: 9363277
Drug: Multiple deep
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple deep breaths inhalation induction (DBI)
Trial: 1489025
Drug: Patient-controlled epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled epidural analgesia (n = 11) with background infusion of 4 ml.h-1 of bupivacaine 0.125% with fentanyl 1 microgram.ml-1 and 3-6 ml bolus doses as required (15 min lockout interval)
Trial: 1489025
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion epidural analgesia (n = 12) with continuous infusion starting at 10 ml.h-1, adjustable up to 25 ml.h-1
Trial: 2872336
Drug: Syrup of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syrup of ipecac 60 ml plus water 480 ml followed by activated charcoal 50 g
Trial: 27990505
Drug: GENESIS Implant
RxNorm normalized name: Genesis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GENESIS Implant System
Trial: 27990505
Drug: PRIMA Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRIMA Implant System
Trial: 24928953
Drug: Endothelin receptor
RxNorm normalized name: Endothelin receptor antagonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endothelin receptor blockade (bosentan)
Trial: 11758896
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (Pulmicort Turbuhaler) 800 microg/day for 4 weeks
Trial: 11758896
Drug: Oral theophylline
RxNorm normalized name: theophylline Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral theophylline (Talotren tablets, 200 mg twice daily) for 4 weeks
Trial: 7964811
Drug: Tizanidine 2
RxNorm normalized name: tizanidine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tizanidine 2 mg
Trial: 24822235
Drug: Tizanidine 4
RxNorm normalized name: tizanidine 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tizanidine 4 mg
Trial: 7964811
Drug: Tizanidine 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tizanidine 8 mg
Trial: 25128802
Drug: Intranasal FluMist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal FluMist seasonal influenza vaccine (3 doses on Days 0, 28, and 56) + rintatolimod (50 μg, 200 μg, or 500 μg)
Trial: 25128802
Drug: Intranasal FluMist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal FluMist seasonal influenza vaccine + rintatolimod
Trial: 21910949
Drug: Galacto-oligosaccharides (GOS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galacto-oligosaccharides (GOS) 4 g in juice, consumed twice daily for 3 weeks
Trial: 21910949
Drug: Placebo, consumed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, consumed twice daily for 3 weeks
Trial: 16055308
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of Haloperidol
Trial: 12109650
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose Gammalinolenic acid (GLA) extracted from Evening Primrose Oil
Trial: 12109650
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose Gammalinolenic acid (GLA)
Trial: 10405233
Drug: Acetaminophen (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (1.0 g) with Lansoprazole (30 mg) after pretreatment with 30 mg once daily for 2 days
Trial: 10405233
Drug: Acetaminophen (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (1.0 g) alone (control session)
Trial: 8639197
Drug: Prochlorperazine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prochlorperazine (10 mg)
Trial: 2123602
Drug: Immediate intravenous
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate intravenous heparin anticoagulation (5,000 U bolus followed by 1,000 U/hour)
Trial: 31364228
Drug: OA-enriched olive
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OA-enriched olive oil (55 mL/day, equivalent to 30 mg OA/day)
Trial: 21214497
Drug: Broadband light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broadband light (400-800 nm) at 180 mW/cm², twice a day for 4 min/session
Trial: 17926613
Drug: Acupoint sticking
RxNorm normalized name: Zit Stick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint sticking therapy with 'Hongwai Zhike Plaster' at Dazhui (GV 14), Dingchuan (EX‐B 1), Tiantu (CV 22) plus common treatment.
Trial: 17926613
Drug: Common treatment
RxNorm normalized name: Common carp
DrugBank: Common carp (DB10614)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Common treatment (giving up smoking, proper exercise).
Trial: 17926613
Drug: Acupoint sticking
RxNorm normalized name: Zit Stick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint sticking therapy.
Trial: 28152236
Drug: N-acetylcysteine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine treatment
Trial: 2695415
Drug: Cefaclor, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor, 40 mg/kg/day in 3 divided doses for 10 days
Trial: 2695415
Drug: Trimethoprim-sulfamethoxazole (TMP-SMX),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim-sulfamethoxazole (TMP-SMX), 1 mg/kg/day (trimethoprim 8 mg, sulfamethoxazole 40 mg) in 2 divided doses for 10 days
Trial: 321094
Drug: Low-dose oxytetracycline
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oxytetracycline (250 mg twice a day)
Trial: 321094
Drug: Sustained-release tetracycline
RxNorm normalized name: Tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release tetracycline hydrochloride
Trial: 321094
Drug: Empirical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical treatment of asymptomatic contacts
Trial: 28438152
Drug: Intervention (community
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention (community pharmacist-led Medicines Use Review)
Trial: 22741052
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg orally, given 6 hours before and 6 to 12 hours after surgery
Trial: 10228254
Drug: Flumazenil (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (0.1 mg/mL)
Trial: 8734180
Drug: Ticlopidine 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine 0.25 g/day and aspirin 0.10 g/day for one month with low molecular weight heparin
Trial: 6343750
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (preoperative gamma-therapy with doses of 4-5 Gy up to 20-25 Gy or 10 Gy up to 50 Gy)
Trial: 3698850
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment alone
Trial: 30240024
Drug: Methylprednisolone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (1 mL intra-articular injection)
Trial: 30240024
Drug: Saline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (1 mL intra-articular injection)
Trial: 27693898
Drug: Fentanyl Buccal
RxNorm normalized name: Fentanyl Buccal Film
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl Buccal Tablet (FBT)
Trial: 27693898
Drug: Fentanyl Buccal
RxNorm normalized name: Fentanyl Buccal Film
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl Buccal Tablet (FBT) and Immediate-release morphine
Trial: 23594026
Drug: Sandwich bone
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sandwich bone augmentation with a bovine pericardium membrane
Trial: 22222005
Drug: EPO therapy
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EPO therapy (5,000 IU subcutaneously at 48 h and 72 h after IS)
Trial: 14998223
Drug: Investigational oxygen-carrying
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigational oxygen-carrying agents
Trial: 6340977
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg loprazolam
Trial: 4049902
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg loprazolam
Trial: 31852704
Drug: Manualised package
RxNorm normalized name: zolmitriptan
DrugBank: Zolmitriptan (DB00315)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manualised package of interventions for TB treatment adherence
Trial: 23565760
Drug: Linagliptin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linagliptin (5 mg once daily)
Trial: 23565760
Drug: Metformin (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (up to 2250 mg/day)
Trial: 21342151
Drug: Thiopental 2.5
RxNorm normalized name: thiopental 2.5 g intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental 2.5 mg/kg
Trial: 21342151
Drug: Propofol 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1.0 mg/kg
Trial: 20467604
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g amoxicillin orally 1 hour before implant placement
Trial: 17367893
Drug: 40-mg controlled-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40-mg controlled-release doxycycline once daily
Trial: 15481334
Drug: Ibuprofen (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (600 mg/6 hr during 3 days)
Trial: 15481334
Drug: Ibuprofen-arginate (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen-arginate (600 mg/6 hr during 3 days)
Trial: 15481334
Drug: Ibuprofen-arginate
RxNorm normalized name: Heme arginate
DrugBank: Heme arginate (DB17310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen-arginate
Trial: 15481334
Drug: Ibuprofen and
RxNorm normalized name: Ibuprofen and Famotidine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen and ibuprofen-arginate
Trial: 11560082
Drug: Caffeine (CAF)
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine (CAF) 6 mg.kg‐1
Trial: 3666158
Drug: Human alpha
RxNorm normalized name: Human alphaherpesvirus 1 Ag
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human alpha interferon 3 x 10(6) units subcutaneously daily for 1 year
Trial: 21911107
Drug: Haloperidol (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (0.25 to 10 mg)
Trial: 21911107
Drug: Risperidone (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (0.25 to 4 mg)
Trial: 21911107
Drug: Olanzapine (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (1.25 to 20 mg)
Trial: 15229466
Drug: Ritonavir (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir (300 mg twice daily for 11 days)
Trial: 12681546
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment via transsylvian transinsular approach
Trial: 3933262
Drug: Intramuscular opiates
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular opiates
Trial: 30156361
Drug: Nebulized terbutaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized terbutaline combined with ipratropium bromide (5 mg terbutaline + 0.5 mg IB)
Trial: 30156361
Drug: Terbutaline alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline alone (5 mg)
Trial: 29843509
Drug: Aprepitant (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprepitant (80 mg) plus Palonosetron (0.075 mg)
Trial: 24957552
Drug: Neo-adjuvant hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neo-adjuvant hormone therapy
Trial: 21488379
Drug: Therapy based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy based on level of kidney function activity
Trial: 18580346
Drug: Intravenous paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous paracetamol 1 g
Trial: 18580346
Drug: 0.9% NaCl
RxNorm normalized name: Trace Metals Additive in 0.9% NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% NaCl 100 ml (placebo)
Trial: 9918521
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen (CE) 0.625 mg
Trial: 7380201
Drug: Cimetidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (300 mg a.c.) added to pancreatic enzyme therapy
Trial: 31233843
Drug: 100 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 μg Fentanyl Sublingual Tablets (FST)
Trial: 31233843
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg Subcutaneous Morphine (SCM)
Trial: 28064386
Drug: Brief supportive‐expressive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief supportive‐expressive therapy (SET)
Trial: 26010143
Drug: GABA extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GABA extract (200 mg GABA) with alcohol drinking (GA)
Trial: 24334868
Drug: Freeze-dried strawberry
RxNorm normalized name: BLACKBERRY MESOCARP FREEZE DRIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Freeze-dried strawberry (FDS) supplementation (2 cups of FDS beverage daily for 6 weeks)
Trial: 19564767
Drug: Lateral fluoroscopic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lateral fluoroscopic guidance (L guidance)
Trial: 19564767
Drug: Both lateral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both lateral and AP fluoroscopic guidance (AP + L guidance)
Trial: 8189743
Drug: Cue exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cue exposure treatment
Trial: 17076961
Drug: Standard cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard cognitive-behavioral treatment
Trial: 3232784
Drug: Intra-operative crystalloid
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-operative crystalloid (1000 ml compound sodium lactate solution)
Trial: 8198262
Drug: Spinal block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal block with 0.5% hyperbaric bupivacaine, 2.5 mL
Trial: 8198262
Drug: Sequential combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential combined spinal-epidural block with 1.5 mL of 0.5% hyperbaric bupivacaine and additional doses if needed
Trial: 28857852
Drug: High-flow nasal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flow nasal cannula at 60 L/min
Trial: 25584489
Drug: Rilotumumab (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rilotumumab (7.5 and 15 mg/kg)
Trial: 18090435
Drug: R-flurbiprofen 400
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: R-flurbiprofen 400 mg/d
Trial: 18090435
Drug: R-flurbiprofen 800
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: R-flurbiprofen 800 mg/d
Trial: 18090435
Drug: R-flurbiprofen 1600
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: R-flurbiprofen 1600 mg/d
Trial: 18090435
Drug: R-flurbiprofen (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-flurbiprofen (all doses)
Trial: 8290188
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg dinoprostone
Trial: 8837563
Drug: Conservative therapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative therapy, n = 22 (control)
Trial: 1331217
Drug: Repirinast 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repirinast 300 mg twice daily for 7 days
Trial: 1331217
Drug: Cromolyn 40
RxNorm normalized name: cromolyn 40 MG/ACTUAT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cromolyn 40 mg single dose
Trial: 23616624
Drug: Bortezomib consolidation
RxNorm normalized name: Bortezomib
DrugBank: Bortezomib (DB00188)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bortezomib consolidation therapy (20 doses over 21 weeks)
Trial: 23616624
Drug: Bortezomib consolidation
RxNorm normalized name: Bortezomib
DrugBank: Bortezomib (DB00188)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bortezomib consolidation therapy
Trial: 20673648
Drug: Verum remedies
RxNorm normalized name: Cinnamomum verum whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verum remedies (Nux Vomica or Coffea Cruda, 30c doses)
Trial: 17188782
Drug: More-aerated snack
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: More-aerated snack (0.45 kcal/ml)
Trial: 17188782
Drug: Less-aerated snack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Less-aerated snack (1.00 kcal/ml)
Trial: 9249617
Drug: Curdlan sulfate
RxNorm normalized name: curdlan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curdlan sulfate (CRDS) 50 mg/70 Kg
Trial: 9249617
Drug: Curdlan sulfate
RxNorm normalized name: curdlan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curdlan sulfate (CRDS) 100 mg/70 Kg
Trial: 9249617
Drug: Curdlan sulfate
RxNorm normalized name: curdlan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curdlan sulfate (CRDS) 200 mg/70 Kg
Trial: 8325044
Drug: Etodolac (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etodolac (400 mg/day)
Trial: 23929243
Drug: Biological therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological therapy (TNF-α inhibitors)
Trial: 23929243
Drug: Targeted physiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted physiotherapy program conducted twice a week for 12 weeks
Trial: 15318955
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate nasal spray (FPANS)
Trial: 15318955
Drug: Placebo nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo nasal spray (PNS)
Trial: 15318955
Drug: Topical steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical steroids (FPANS)
Trial: 11166493
Drug: Cortisol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol (20 mg)
Trial: 8176575
Drug: Metered-dose inhaler
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered-dose inhaler with spacer (Nebuhaler)
Trial: 30482701
Drug: Bivalirudin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalirudin (1 mg/kg bolus followed by 2.5 mg/kg/h infusion)
Trial: 30482701
Drug: Heparin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (4 mg/kg)
Trial: 31904760
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein (60 g/day)
Trial: 28012280
Drug: Casein (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casein (60 g/day)
Trial: 28012280
Drug: Milk fat
RxNorm normalized name: MILK FAT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk fat high in MC-SFA (63 g/day)